April 16, 2025 — An artificial intelligence (AI) program trained to review images from a common medical test can detect ...
April 9, 2025 — Merit Medical Systems has announced the U.S. commercial release of its Ventrax Delivery System. Ventrax ...
April 15, 2025 – DESKi recently announced FDA clearance for HeartFocus, its AI-enabled heart exam software that empowers ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
On April 9, 2025, the world’s first multisector advocacy movement dedicated to stroke — the Global Stroke Action ...
April 1, 2025 — UltraSight recently announced the presentation at the American College of Cardiology (ACC) Annual ...

Cardiology practices face mounting financial pressures — rising operational costs, declining reimbursements, and complex ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
April 10, 2025 — The American College of Cardiology’s (ACC’s) five-year Strategic Plan includes a major initiative ...
April 9, 2025 — Idorsia Ltd recently announced that the US Food & Drug Administration (FDA), after having released ...
April 7, 2025 — CardioVia, a medical device company specializing in advanced cardiac care solutions, has received U.S ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
April 4, 2025 — Viz.ai has been named an Award Winner in the 2025 Edison Awards, for the third year in a row. Viz HCM ...
April 3, 2025 — Tower Health and Siemens Healthineers recently announced a 10-year agreement focused on equipment ...
March 31, 2025 — Using intravascular imaging (IVI) to guide stent implantation during complex stenting procedures is ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
March 31, 2025 -— BioCardia, Inc. recently announced two-year outcomes from the double-blind randomized placebo ...
March 30, 2025 — Medtronic has announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Data ...
March 31, 2025 — iRhythm Technologies, Inc. has announced results from two large real-world retrospective analyses ...